GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
This Quarter Return
+14.81%
1 Year Return
+15.68%
3 Year Return
+21.54%
5 Year Return
+22.27%
10 Year Return
–
AUM
$169M
AUM Growth
+$169M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
42.58%
Holding
117
New
20
Increased
23
Reduced
35
Closed
19
Top Buys
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$11.3M |
| 2 |
HIMX
Himax Technologies
HIMX
|
$6.3M |
| 3 |
Meta Platforms (Facebook)
META
|
$4.59M |
| 4 |
GOOS
Canada Goose Holdings
GOOS
|
$3.19M |
| 5 |
Golar LNG
GLNG
|
$2.6M |
Top Sells
| 1 |
Alibaba
BABA
|
$6.89M |
| 2 |
MACOM Technology Solutions
MTSI
|
$4.02M |
| 3 |
NextDecade
NEXT
|
$3.13M |
| 4 |
Dycom Industries
DY
|
$2.64M |
| 5 |
BEDU
Bright Scholar Education Holdings
BEDU
|
$2.57M |
Sector Composition
| 1 | Technology | 24.56% |
| 2 | Healthcare | 23.95% |
| 3 | Communication Services | 10.09% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Industrials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
1
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $15.8M | 3.32% | 2,684,848 +1,918,400 | +250% | +$11.3M |
|
|
HIMX
2
Himax Technologies
HIMX
$1.42B
| $14.1M | 2.96% | 1,286,600 +576,600 | +81% | +$6.3M |
|
|
3
Meta Platforms (Facebook)
META
$1.86T
| $9.99M | 2.1% | 58,450 +26,850 | +85% | +$4.59M |
|
|
ADMS
4
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $7.06M | 1.49% | 333,515 +70,000 | +27% | +$1.48M |
|
5
Axogen
AXGN
$743M
| $5.3M | 1.12% | 273,751 -21,600 | -7% | -$418K |
|
6
Lumentum
LITE
$9.28B
| $5.29M | 1.11% | 97,300 +12,000 | +14% | +$652K |
|
|
SBBP
7
DELISTED
Strongbridge Biopharma plc.
SBBP
| $3.92M | 0.83% | 567,895 -1 | -0% | -$7 |
|
|
GOOS
8
Canada Goose Holdings
GOOS
$1.26B
| $3.6M | 0.76% | 175,000 +155,000 | +775% | +$3.19M |
|
|
9
Golar LNG
GLNG
$4.48B
| $3.28M | 0.69% | 145,000 +115,000 | +383% | +$2.6M |
|
10
NVIDIA
NVDA
$4.24T
| $3.04M | 0.64% | 17,000 +9,100 | +115% | +$1.63M |
|
11
Summit Therapeutics
SMMT
$17.6B
| $3.03M | 0.64% | 242,113 +125,000 | +107% | +$1.56M |
|
|
MB
12
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $2.9M | 0.61% | 112,200 +5,900 | +6% | +$152K |
|
13
NetEase
NTES
$86.2B
| $2.59M | 0.54% | 9,800 +1,700 | +21% | +$448K |
|
|
NVRO
14
DELISTED
NEVRO CORP.
NVRO
| $2.55M | 0.54% | 28,100 -3,900 | -12% | -$354K |
|
|
NPTN
15
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.55M | 0.54% | 458,302 +36,998 | +9% | +$206K |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | 0.53% | 30,700 -9,300 | -23% | -$766K |
|
17
Advanced Micro Devices
AMD
$264B
| $2.52M | 0.53% | 197,550 +47,550 | +32% | +$606K |
|
|
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.42M | 0.51% | 49,800 -12,159 | -20% | -$591K |
|
|
MYND
19
Mynd.ai
MYND
$26.8M
| $2.28M | 0.48% | +80,000 | New | +$2.28M |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $2.25M | 0.47% | +64,100 | New | +$2.25M |
|
21
JPMorgan Chase
JPM
$829B
| $2.24M | 0.47% | 23,500 -11,500 | -33% | -$1.1M |
|
22
Sarepta Therapeutics
SRPT
$1.78B
| $2.11M | 0.44% | 46,520 -16,700 | -26% | -$757K |
|
23
Incyte
INCY
$16.5B
| $2.1M | 0.44% | 18,000 +5,500 | +44% | +$642K |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.05M | 0.43% | 50,000 +20,000 | +67% | +$818K |
|
|
EVBG
25
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2M | 0.42% | 75,750 -31,800 | -30% | -$840K |
|